THE CURATIVE TREATMENT BY RADIOTHERAPY ALONE OF STAGE-I NON-SMALL-CELL CARCINOMA OF THE LUNG

被引:105
|
作者
GAUDEN, S
RAMSAY, J
TRIPCONY, L
机构
[1] Queensland Radium Institute, Royal Brisbane Hospital, Herston, QLD
关键词
LUNG CANCER; NON-SMALL CELL CANCER; RADIOTHERAPY;
D O I
10.1378/chest.108.5.1278
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
This review was initiated to assess the outcome of treatment with radical radiotherapy with curative intent for patients diagnosed as having stage I non-small cell lung cancer, The study involved a retrospective review of 347 patients with T1 and T2N0M0 tumors treated at the Queensland Radium Institute during the period 1988 to 1992. The main reasons for not proceeding to surgery included poor performance status, old age, or refusal to submit to surgery, The median age for the group was 70 years, with the range being 34 to 90 years, Patients in this group were all treated by a standard technique involving external-beam radiotherapy to 50 Gy, minimum tumor dose, in 20 fractions over 4 weeks, The overall survival rate was 27% at 5 years with a median survival of 27.9 months, The 5-year recurrence-free survival was 23% with the median being 19.5 months, There was a strong correlation of survival to tumor size with g-year survival rates being 32% and 21% for T1 and T2 tumors, respectively, Multivariate analysis found only T stage to be associated with overall survival (p<0.01). In addition, the analysis showed that age younger than 70 years was a prognostic factor that approached statistical significance at the p<0.05 level of significance, We conclude from this large series of patients with stage I non-small cell lung cancer that radical radiotherapy with curative intent may be a viable alternative to surgery in those patients who either refuse surgery or are judged to be unfit for operation.
引用
收藏
页码:1278 / 1282
页数:5
相关论文
共 50 条
  • [31] SITES OF RECURRENCE IN RESECTED STAGE-I NON-SMALL-CELL LUNG-CANCER - A GUIDE FOR FUTURE STUDIES
    FELD, R
    RUBINSTEIN, LV
    WEISENBERGER, TH
    JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (12) : 1352 - 1358
  • [32] POSTSURGICAL ADJUVANT THERAPY IN STAGE-I, STAGE-II, AND STAGE-IIIA NON-SMALL-CELL LUNG-CANCER
    LAD, TE
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1990, 4 (06) : 1111 - 1119
  • [33] Outcomes After Stereotactic Lung Radiotherapy or Wedge Resection for Stage I Non-Small-Cell Lung Cancer
    Grills, Inga S.
    Mangona, Victor S.
    Welsh, Robert
    Chmielewski, Gary
    McInerney, Erika
    Martin, Shannon
    Wloch, Jennifer
    Ye, Hong
    Kestin, Larry L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (06) : 928 - 935
  • [35] Mortality after radiotherapy or surgery in the treatment of early stage non-small-cell lung cancer
    Mueller, J. A.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S117 - S118
  • [36] RADIATION-THERAPY FOR MEDICALLY INOPERABLE STAGE-I AND STAGE-II NON-SMALL-CELL LUNG-CANCER
    ARMSTRONG, JG
    MINSKY, BD
    CANCER TREATMENT REVIEWS, 1989, 16 (04) : 247 - 255
  • [37] Role of Postoperative Radiotherapy for Patients with Pathological Stage III Non-Small-Cell Lung Cancer after Curative Resection
    Kim, Mi Young
    Wu, Hong-Gyun
    Kim, Hak Jae
    Heo, Dae-Seog
    Kim, Young Whan
    Kim, Dong-Wan
    Lee, Se-Hoon
    Kim, Joo Hyun
    Kim, Young Tae
    Kang, Chang-Hyun
    RADIATION ONCOLOGY JOURNAL, 2011, 29 (01): : 44 - 52
  • [38] Treatment Burden of Medicare Beneficiaries With Stage I Non-Small-Cell Lung Cancer
    Presley, Carolyn J.
    Soulos, Pamela R.
    Tinetti, Mary
    Montori, Victor M.
    Yu, James B.
    Gross, Cary P.
    JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (02) : E98 - E107
  • [39] Guideline for radiotherapy with curative intent in patients with early-stage medically inoperable non-small-cell lung cancer
    Falkson, C. B.
    Vella, E. T.
    Yu, E.
    El-Mallah, M.
    Mackenzie, R.
    Ellis, P. M.
    Ung, Y. C.
    CURRENT ONCOLOGY, 2017, 24 (01) : E44 - E49
  • [40] Treatment of stage I-III non-small-cell lung cancer in the elderly
    Gridelli, Cesare
    Maione, Paolo
    Rossi, Antonio
    ONCOLOGY-NEW YORK, 2006, 20 (04): : 373 - 380